Shares of Tilray Inc (NASDAQ:TLRY - Get Free Report) shot up 3.2% on Monday . The company traded as high as $0.68 and last traded at $0.67. 9,971,595 shares changed hands during trading, a decline of 77% from the average session volume of 44,183,152 shares. The stock had previously closed at $0.65.
Analyst Ratings Changes
Separately, Canaccord Genuity Group increased their price objective on Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a research report on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $2.70.
View Our Latest Stock Report on TLRY
Tilray Price Performance
The firm has a market cap of $639.11 million, a PE ratio of -2.27 and a beta of 2.13. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The company has a 50 day moving average price of $0.89 and a 200 day moving average price of $1.28.
Tilray (NASDAQ:TLRY - Get Free Report) last posted its earnings results on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The firm had revenue of $210.90 million during the quarter, compared to analyst estimates of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. Tilray's revenue for the quarter was up 8.7% compared to the same quarter last year. On average, sell-side analysts expect that Tilray Inc will post -0.2 EPS for the current year.
Hedge Funds Weigh In On Tilray
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Lido Advisors LLC purchased a new position in shares of Tilray during the 4th quarter worth approximately $28,000. Verdence Capital Advisors LLC purchased a new position in Tilray during the fourth quarter worth $29,000. Dudley Capital Management LLC purchased a new position in Tilray during the fourth quarter worth $29,000. Ameritas Advisory Services LLC acquired a new position in shares of Tilray in the fourth quarter worth $32,000. Finally, Newman Dignan & Sheerar Inc. lifted its position in shares of Tilray by 61.9% in the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after acquiring an additional 10,000 shares in the last quarter. Institutional investors and hedge funds own 9.35% of the company's stock.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
